Crossmark

PRO-based follow-up as a means of self-management support – an interpretive description of the patient perspective

Crossref DOI link: https://doi.org/10.1186/s41687-018-0067-0

Published Online: 2018-09-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mejdahl, Caroline Trillingsgaard http://orcid.org/0000-0001-7361-6082
Schougaard, Liv Marit Valen

Hjollund, Niels Henrik

Riiskjær, Erik

Thorne, Sally

Lomborg, Kirsten
Funding

Funding for this research was provided by:

Novo Nordisk (NNF16OC0022122)

Aarhus Universitet
License Information

Text and Data Mining valid from 2018-09-05
More Information

Article History

Received: 25 March 2018

Accepted: 20 August 2018

First Online: 5 September 2018

Ethics approval and consent to participate

: The study was approved by the Danish Data Protection Agency (Identification no. 2015–41-4119). According to Danish law, this kind of qualitative study does not require notification to the Committee on Biomedical Research Ethics. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed oral and written consent were obtained and all general requirements for health science research were followed.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.